Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 114   

Articles published

SHP 5,680.00 +90.00 (1.61%)
price chart
Which is Your Best Pharma Bet: GlaxoSmithKline plc, AstraZeneca plc Or Shire PLC?
The mantra of expand and diversify seems to have gone rather out of fashion since the global financial crisis and recession. These days the rallying cry is: concentration and focus.
Berenberg Bank Cuts Shire PLC Price Target to GBX 6200 (SHP)
Shire PLC logo Shire PLC (LON:SHP) had its price objective cut by Berenberg Bank from GBX 6,300 ($97.78) to GBX 6,200 ($96.23) in a report released on Tuesday, Market Beat Ratings reports.
Shire PLC's Neutral Rating Reaffirmed at RBC Capital (SHP)  Mideast Time
Shire PLC PT Lowered to GBX 6200 (SHP)  WKRB News
As AstraZeneca plc Slumps, Should You Sell And Buy Shire PLC?
Shire's growth is exploding, and investors are clamouring to get their hands on the company's shares. Excluding exceptional items, the company delivered earnings growth of 38% last year.
Zacks Rating on Shire plc
Shire plc (NASDAQ:SHPG): 9 Analyst have given the stock of Shire plc (NASDAQ:SHPG) a near short term price target of $275.11.
SHIRE PLC - Director Declaration  Stockhouse
Earnings Watch: Shire plc (NASDAQ:SHPG)  Markets Daily
Is SkyePharma PLC A Better Buy Than Shire PLC Or Hikma Pharmaceuticals Plc?
The gains haven't been equal, though. Investors in SkyePharma can rightfully feel smug, as their company has risen by 370% since June 2013, compared to 104% for Hikma and 165% for Shire. The only problem is that SkyePharma shares are down by 17% ...
HSBC initiates coverage of European pharmaceuticals Astra, GSK, Hikma and Shire  Yahoo Finance UK
Is Now The Perfect Time To Buy Informa PLC, Banco Santander SA & Shire PLC?
Shares in publishing and events company Informa (LSE: INF) have surged by over 6% today after the company reported a rise in profit for the first half of the year as well as confirming its guidance for the full year.
Shire plc (SHPG) Misses Q2 EPS by 18c; Updates on Outlook
Shire plc (NASDAQ: SHPG) reported Q2 EPS of $2.63, $0.18 worse than the analyst estimate of $2.81. Revenue for the quarter came in at $1.56 billion versus the consensus estimate of $1.59 billion.
Pharma Showdown: Should You Buy GlaxoSmithKline plc Or Shire PLC?
If you're struggling to choose between GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP), you're not alone. Glaxo and Shire are two of the UK's premier pharmaceutical companies, with their individual strengths and weaknesses. And choosing between the ...
Ratings Watch – Shire plc (NASDAQ:SHPG)
Shares of Shire plc (NASDAQ:SHPG) have been given a consensus rating of 1.77 by brokerage analysts covering the stock. This number is based on a simplified ratings scale of 1-5 where 1 represents a Strong Buy and 5 a Strong Sell.
“Buy High, Sell Higher”: A Look At Shire plc, ITV plc, Sirius Minerals plc ...
Market timing can be one of the most important aspects to consider when investing. “Buy low, sell high” is widely considered as the most simple rule to investing.